Slide 1: Fiscal 2022 year to date results
Fiscal 2022 year to date results (nine months ended March 31, 2022) Ron Delia CEO Michael Casamento CFO May 3, 2022 US May 4, 2022 Australia NYSE: AMCR | ASX: AMC
Slide 2: Disclaimers
Disclaimers Cautionary Statement Regarding Forward-Looking Statements This document contains certain statements that are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generall
Slide 3: Safety
Safety Guided by our values. Committed to our goal of ‘no injuries’ Recordable-case frequency rate Amcor Values (per million hours worked) 11.2 Includes impact of acquired businesses 4.1 2.8 2.0 2.2 2.1 0.4 2005 2010 2015 2020 2021 3Q22 3Q22 OSHA Notes: Recordable cases per 1,000,000 hours worked. A
Slide 4: Key messages
Key messages 1. Delivered strong March quarter across the business 2. Exceptional management of sales mix and inflation 3. Raised fiscal 2022 EPS guidance 4. Increasing investments for growth 4
Slide 5: Strong March quarter and year to date financial result
Strong March quarter and year to date financial result Strong result across all key metrics and EPS guidance raised Increasing year to date Net sales EBIT EPS shareholder returns $3,708M $427M 20.4 cents • $973 million cash returns 3Q 3Q 3Q • $423 million share repurchases +16% +9% +15% • Quarterly
Slide 6: Growth in priority segments drives mix and margin benefits
Growth in priority segments drives mix and margin benefits Protein Healthcare Healthcare PremiumCoffee Premium Coffee PetFood Pet Food Hot-Fill Beverage Hot-Fill Beverage Hot-Fill Beverage Total Amcor sales >$4 billion across priority segments Common segment features: Large addressable markets (>$1b
Slide 7: Flexibles segment
Flexibles segment Net sales growth of 5% in 3Q. Continued focus on managing mix and inflation YTD YTD Comparable Year to date highlights constant 3Q21 3Q22 currency • Sales of $8.2bn includes price increases of ~$810 Net sales ($m) 7,350 8,184 +3% million (11% growth) related to higher raw material
Slide 8: Rigid Packaging segment
Rigid Packaging segment Return to earnings growth in 3Q as expected YTD YTD Comparable Year to date highlights constant 3Q21 3Q22 currency • Sales of $2.5bn includes price increases of ~$300 million Net sales ($m) 2,059 2,451 +5% (14% growth) related to higher raw material costs Adjusted EBIT ($m) 2
Slide 9: Cash flow, balance sheet & cash returns to shareholders
Cash flow, balance sheet & cash returns to shareholders Continued capacity to increase capex and cash returns to shareholders Year to date highlights YTD YTD Year to date cash flow ($ million) 3Q21 3Q22 • Growing EBITDA Adjusted EBITDA 1,455 1,507 • Working capital impacted by timing of raw material
Slide 10: Fiscal 2022 guidance
Fiscal 2022 guidance For the year ending 30 June 2022 the Company expects: Adjusted EPS growth of approximately 9.5 to 11% (previously 7 to 11%) on a comparable constant currency basis, or approximately 79.5 to 81.0 cents per share on a reported basis assuming current exchange rates prevail through
Slide 11: Investment case: Strong foundation for growth and value creation
Investment case: Strong foundation for growth and value creation Global leader in primary consumer and healthcare packaging with a strong track record Consistent growth from priority segments, emerging markets and innovation Growing cash flow and strong balance sheet provides ongoing capacity to inv
Slide 12: Multiple drivers of organic growth
Multiple drivers of organic growth Priority Emerging Innovation Segments Markets >$4 bn sales in higher growth, >$3 bn Emerging Markets sales Driving value through higher value segments: across 27 countries: differentiated packaging: Healthcare Protein Pet food MSD volume growth across Emerging Mark
Slide 13: Growing demand for differentiated, sustainable product platforms
Growing demand for differentiated, sustainable product platforms up to 30% PCR up to 58% reduction pre-qualified in the U.S. content included in carbon footprint Leveraging our global footprint to expand and localise capacity as demand grows Wisconsin Future Investment investment underway opportunit
Slide 14: Increasing investments for organic growth
Increasing investments for organic growth Capitalizing on high quality growth opportunities UK - Protein Ireland - Healthcare China – Food & Personal care Brazil - Healthcare & Protein Italy – AmLite Heatflex Increasing capex to 4-5% of sales 14
Slide 15: Sustainability: Partnering and investing for the future
Sustainability: Partnering and investing for the future Collaborating with others for long-term impact Providing insights and Creating demand for Increasing our expertise recycled material ambitions Net zero GHG emissions by 2050 Exxtend™ Pathway aligned with Science Based Targets 15 15
Slide 16: Key messages
Key messages 1. Delivered strong March quarter across the business 2. Exceptional management of sales mix and inflation 3. Raised fiscal 2022 EPS guidance 4. Increasing investments for growth 16
Slide 17: Appendix slides
Appendix slides Supplementary schedules and reconciliations
Slide 18: FX translation impact
FX translation impact Nine months ended March 31, 2022 Combined net income currency currency impact exposures(1) Total currency impact $ million Adjusted EBIT (13) EUR, 20-30% Adjusted net income (10) EUR:USD Euro weakened vs USD, Average USD million impact on USD to EUR rate 3Q22 0.8713 vs 3Q22 adj
Slide 19: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 19
Slide 20: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 20
Slide 21: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 21
Slide 22: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 22
Slide 23: Reconciliations of non-GAAP financial measures
Reconciliations of non-GAAP financial measures 23